Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients

BACKGROUND: The aim of this study was to investigate the potential of cell-free DNA (cfDNA) as a disease biomarker in oesophageal squamous cell carcinoma (ESCC) that can be used for treatment response evaluation and early detection of tumour recurrence. METHODS: Matched tumour tissue, pre- and post-...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Pei, Wei, Jiacong, Geng, Yiqun, Chen, Shaobin, Terpstra, Miente Martijn, Huang, Qiongyi, Zhang, Qian, Su, Zuoqing, Yu, Wanchun, Su, Min, Kok, Klaas, van den Berg, Anke, Gu, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701116/
https://www.ncbi.nlm.nih.gov/pubmed/31429737
http://dx.doi.org/10.1186/s12885-019-6025-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701116/
https://www.ncbi.nlm.nih.gov/pubmed/31429737
http://dx.doi.org/10.1186/s12885-019-6025-2

Ejemplares similares